These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients. Murayama T, Sakai N, Yamada T, Takano T. Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477 [Abstract] [Full Text] [Related]
28. Effect of vitamin E and mannitol on renal calcium oxalate retention in experimental nephrolithiasis. Thamilselvan S, Selvam R. Indian J Biochem Biophys; 1997 Jun; 34(3):319-23. PubMed ID: 9425753 [Abstract] [Full Text] [Related]
36. Metabolic studies on the formation of calcium oxalate stones, with special emphasis on vitamin B6 and uric acid metabolism. Mayer GG, Chase T, Farvar B, Waidh MA, Longo F, Karp F, Zinsser HH. Bull N Y Acad Med; 1968 Jan; 44(1):28-44. PubMed ID: 5239150 [No Abstract] [Full Text] [Related]
37. [An experimental study of effect of different extracts of Alisma orientalis on urinary calcium oxalate stones formation in rats]. Cao ZG, Liu JH, Radman AM, Wu JZ, Ying CP, Zhou SW. Zhongguo Zhong Yao Za Zhi; 2003 Nov; 28(11):1072-5. PubMed ID: 15615421 [Abstract] [Full Text] [Related]
38. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, Schröder FH. Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009 [Abstract] [Full Text] [Related]
40. An evaluation of the physicochemical risk for renal stone disease during pregnancy. Smith CL, Kristensen C, Davis M, Abraham PA. Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]